Common causes of postmenopausal bleeding include atrophy and fibroids. Learn about risk factors, treatments, and when to ...
A population-based study explores the relationship between preinjury antidepressant use and short-term outcomes after ...
An investigational anti-clotting medication, asundexian, has demonstrated a reduction in the risk of a second ischemic ...
The factor XIa inhibitor asundexian reduced recurrent ischemic stroke without increasing major or minor bleeding in patients ...
For patients with noncardioembolic ischemic stroke or high-risk transient ischemic attack, asundexian, a factor XIa inhibitor ...
In the CKD population treated with oral anticoagulants for atrial fibrillation, major bleeding is more likely in male patients and those with congestive heart failure, vascular disease, and a history ...
The researchers explored the association of sex with outcomes among patients treated with ticagrelor monotherapy vs ticagrelor plus aspirin. Baseline factors, such as older age and kidney impairment, ...
Novel agent abelacimab has potential to be a safer anticoagulant, according to the randomized AZALEA-TIMI 71 trial. The trial had been stopped early because of a surprisingly large reduction in bleeds ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results